Studies utilizing rat models of Achilles tendon injury have shown improved biomechanical properties, enhanced collagen organization, and accelerated healing kinetics following BPC-157 administration
The size of the liver-fat result also depends on what the liver had to give
The recommendations are not equivalent to FDA approval and the agency is not required to follow the committee's advice
Timing Baseline Monitoring guidance is pathway-based and cautious because SLU-PP-332 has limited human monitoring data
Gross necropsy and histopathologic examination of animals receiving high-dose BPC-157 found no organ damage in liver, spleen, lung, kidney, brain, thymus, prostate, ovaries, or gastric wall
They may also have subclinical conditions that could be affected by metabolic changes